Ads by Google
Giant Eagle will add about 100 prescription drugs to its $4 generic drug program, raising its number of products available at that price to more than 400.
Interpol plans to join the fight to stop the growing trade of counterfeit antiretroviral, tuberculosis and malaria drugs in Africa.
Employer purchasers will discover how URAC's new Pharmacy Benefit Management Accreditation standards apply to their efforts towards value-based purchasing.
WHO called on developed countries to make antiretroviral drugs and other medications more affordable for developing countries.
Online drug sales in 2006 from Canadian pharmacies to U.S. consumers dropped about 50%, from $420 million Canadian dollars in 2005 to $211 million Canadian dollars last year, according to data from IMS Health, the Philadelphia Inquirer reports. Drug sales across the border to U.S. patients -- once "a hot trend" -- have been suppressed by several factors, including threats from U.S. pharmaceutical companies to stop supplying drugs to Canadian firms, rising drug costs in Canada, a weaker U.S.
FDA this year has not visited as many as two-thirds of foreign companies that manufacture medications or medications components imported by the U.S. subject for inspection.
Sales growth for prescription drugs in 2008 is expected to increase at the lowest rate in decades.
House Energy to address a recent decrease in FDA inspections of foreign companies that manufacture medications and medication ingredients.
House will not have enough time this year to develop and pass legislation that would allow FDA to approve generic versions of biotechnology drugs.
U.S. Department of Health and Human Services announced two new tools to help pharmacies provide better quality services to people with limited health literacy.
Roche's organ-rejection drug CellCept increases the risk of birth defects and miscarriage during the first trimester of pregnancy.
Scientists can finally get a close-up look at the drugs' molecular target the b2-adrenergic receptor.
The percentage of young adults who take anticholesterol and hypertension medications has increased significantly in recent years.
Washington Post examined physicians who sell prescription drugs to patients.
Ranbaxy Pharmaceuticals has received tentative approval from FDA to manufacture and market Valsartan Tablets.
SAMHSA is announcing the launch of a first-of-its-kind pilot program for providing point-of-sale substance abuse prevention information sheets to the consumers of highly abused prescription drugs.
FDA issued an Early Communication about an Ongoing Safety Review of Aprotinin Injection, a drug used to control bleeding during heart surgery.
Although doctors routinely use IV antibiotics to cure patients with severe urinary tract infections, a new review from suggests that oral antibiotics work just as well.
Approximately one-third of the world's population is infected with Mycobacterium tuberculosis, the bacterium that causes TB, and an estimated 1.6 million people died of the disease in 2005.
KV Pharmaceutical Company has received approval from FDA on its application for the 100 mg and 200 mg strengths of Morphine ER Tablets.
Lacromin, a recombinant growth factor for cell culture media outperforms transferrin and provides a cost-effective solution to rising transferrin costs.
Amneal Pharmaceutical finalized a joint venture partnership to develop, manufacture, market and distribute several ophthalmic pharmaceuticals for the United States market.
Delaware has approved a new rule that will require prescriptions for Medicaid beneficiaries to be written on tamper-resistant prescription drug pads.
CMS likely will not restrict Medicare coverage for drug-coated stents in response to recent concerns that they can increase risk for blood clots.
Democrats reintroduced legislation that would require the federal government to negotiate prices directly with pharmaceutical companies for medications under the Medicare prescription drug benefit.